Abstract
Rickets associated with liver disease is believed to be caused by malabsorption of vitamin D and Ca and decreased hepatic 25-hydroxylation of vitamin D. 1,25-(OH)2D, normally synthesized in the kidney from 25-hydroxyvitamin D (25-OHD), theoretically should bypass the blocks in vitamin D metabolism. Two patients had radiographic and biochemical evidence of rickets with severe neonatal hepatitis and extrahepatic biliary atresia. Both received phenobarbital to enhance bile flow. 1,25-(OH)2D was initially given orally (0.10 μg/kg/day) without improvement. Thereafter, i.m. divided doses (0.20 μg/kg/day) were given with complete biochemical, bone mineral (photon absorptiometric analysis) and radiographic evidence of healing.
I.M. 1,25-(OH)2D which theoretically overcomes blocks in vitamin D metabolism, can be effectively used in infantile biliary rickets. Healing occurs in spite of continuously low 25-OHD. The need for higher doses of 1,25-(OH)2D, four times the “physiologic dose”, may reflect enhanced catabolism or end organ resistance.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Heubi, J., Tsang, R., Steichen, J. et al. THE USE OF 1,25-DIHYDROXYCHOLECALCIFEROL (1,25-(OH)2 D) IN THE TREATMENT OF RICKETS WITH NEONATAL LIVER DISEASE. Pediatr Res 11, 515 (1977). https://doi.org/10.1203/00006450-197704000-00873
Issue Date:
DOI: https://doi.org/10.1203/00006450-197704000-00873